Skip to main content

Table 3 Univariate predictors of 6-month survival*

From: Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study

Characteristics Non survivors n = 25 Survivors n = 55 p
Characteristics at ICU admission    
Age 40 ± 9 42 ± 9 0.19
Sex (M/F) 8/17 19/36 0.99
SAPSII on admission 55 ± 25 42 ± 16 0.02
Glasgow on admission 10 ± 5 13 ± 4 0.05
HIV infection    
Initial HIV diagnosis 8 (32) 6 (11) 0.03
Stage C 20 (80) 43 (78) 0.99
CD4 count at admission (/mm3) 154 ± 201 215 ± 198 0.21
AIDS related diagnosis at ICU admission 16 (64) 24 (44) 0.15
Care in ICU    
Mechanical ventilation 19 (76) 20 (36) 0.0015
Duration of ventilation (days) 10 ± 13 3 ± 8 0.0001
Vasoactive drugs 6 (24) 5 (9) 0.09
Duration of vasoactive drugs use (days) 1.7 ± 2.5 0.6 ± 1.3 0.006
Use of HAART    
HAART at ICU admission 11 (44) 35 (64) 0.14
immunovirological success at ICU admission 3 (12) 17 (31) 0.096
HAART during ICU stay 9 (36) 21 (38) 0.99
  1. *Data are presented as No. (%) or mean ± SD.